These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
765 related items for PubMed ID: 1638680
41. Micronuclei and gene mutations in transgenic big Blue((R)) mouse and rat fibroblasts after exposure to the epoxide metabolites of 1, 3-butadiene. Erexson GL, Tindall KR. Mutat Res; 2000 Dec 20; 472(1-2):105-17. PubMed ID: 11113703 [Abstract] [Full Text] [Related]
42. Comparative metabolism of low concentrations of butadiene and its monoepoxide in human and monkey hepatic microsomes. Dahl AR, Henderson RF. Inhal Toxicol; 2000 May 20; 12(5):439-51. PubMed ID: 10880138 [Abstract] [Full Text] [Related]
43. Kinetics of propylene oxide metabolism in microsomes and cytosol of different organs from mouse, rat, and humans. Faller TH, Csanády GA, Kreuzer PE, Baur CM, Filser JG. Toxicol Appl Pharmacol; 2001 Apr 01; 172(1):62-74. PubMed ID: 11264024 [Abstract] [Full Text] [Related]
44. Metabolism of 1,3-butadiene by lung and liver microsomes of rats and mice repeatedly exposed by inhalation to 1,3-butadiene. Bond JA, Martin OS, Birnbaum LS, Dahl AR, Melnick RL, Henderson RF. Toxicol Lett; 1988 Nov 01; 44(1-2):143-51. PubMed ID: 3188072 [Abstract] [Full Text] [Related]
46. Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites. Pianalto KM, Hartman JH, Boysen G, Miller GP. Toxicol Lett; 2013 Nov 25; 223(2):221-7. PubMed ID: 24021170 [Abstract] [Full Text] [Related]
47. Absence of detectable P450 2E1 in bone marrow of B6C3F1 mice: relevance to butadiene-induced bone marrow toxicity. Genter MB, Recio L. Fundam Appl Toxicol; 1994 Apr 25; 22(3):469-73. PubMed ID: 8050641 [Abstract] [Full Text] [Related]
49. Kinetics of ethylene and ethylene oxide in subcellular fractions of lungs and livers of male B6C3F1 mice and male fischer 344 rats and of human livers. Li Q, Csanády GA, Kessler W, Klein D, Pankratz H, Pütz C, Richter N, Filser JG. Toxicol Sci; 2011 Oct 25; 123(2):384-98. PubMed ID: 21785163 [Abstract] [Full Text] [Related]
50. 1,3-Butadiene: linking metabolism, dosimetry, and mutation induction. Bond JA, Csanady GA, Gargas ML, Guengerich FP, Leavens T, Medinsky MA, Recio L. Environ Health Perspect; 1994 Nov 25; 102 Suppl 9(Suppl 9):87-94. PubMed ID: 7698092 [Abstract] [Full Text] [Related]
51. Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice. Himmelstein MW, Turner MJ, Asgharian B, Bond JA. Toxicology; 1996 Oct 28; 113(1-3):306-9. PubMed ID: 8901914 [Abstract] [Full Text] [Related]
52. 1,3-Butadiene: toxicity and carcinogenicity in laboratory animals and in humans. Melnick RL, Huff J. Rev Environ Contam Toxicol; 1992 Oct 28; 124():111-44. PubMed ID: 1732994 [Abstract] [Full Text] [Related]
53. Species differences in urinary butadiene metabolites; identification of 1,2-dihydroxy-4-(N-acetylcysteinyl)butane, a novel metabolite of butadiene. Sabourin PJ, Burka LT, Bechtold WE, Dahl AR, Hoover MD, Chang IY, Henderson RF. Carcinogenesis; 1992 Sep 28; 13(9):1633-8. PubMed ID: 1394848 [Abstract] [Full Text] [Related]
54. A physiological toxicokinetic model for 1,3-butadiene in rodents and man: blood concentrations of 1,3-butadiene, its metabolically formed epoxides, and of haemoglobin adducts--relevance of glutathione depletion. Csanády GA, Kreuzer PE, Baur C, Filser JG. Toxicology; 1996 Oct 28; 113(1-3):300-5. PubMed ID: 8901913 [Abstract] [Full Text] [Related]
55. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice. Lin DX, Lang NP, Kadlubar FF. Drug Metab Dispos; 1995 Apr 28; 23(4):518-24. PubMed ID: 7600922 [Abstract] [Full Text] [Related]
56. Genotoxicity of 1,3-butadiene and its epoxy intermediates. Walker VE, Walker DM, Meng Q, McDonald JD, Scott BR, Seilkop SK, Claffey DJ, Upton PB, Powley MW, Swenberg JA, Henderson RF, Health Review Committee. Res Rep Health Eff Inst; 2009 Aug 28; (144):3-79. PubMed ID: 20017413 [Abstract] [Full Text] [Related]
57. Dose responses for DNA adduct formation in tissues of rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-[(14)C]-butadiene. Booth ED, Kilgour JD, Robinson SA, Watson WP. Chem Biol Interact; 2004 Mar 15; 147(2):195-211. PubMed ID: 15013821 [Abstract] [Full Text] [Related]
58. Gender differences in the metabolism of 1,3-butadiene in Sprague-Dawley rats following a low level inhalation exposure. Thornton-Manning JR, Dahl AR, Bechtold WE, Griffith WC, Pei L, Henderson RF. Carcinogenesis; 1995 Nov 15; 16(11):2875-8. PubMed ID: 7586213 [Abstract] [Full Text] [Related]
59. Metabolic inactivation of five glycidyl ethers in lung and liver of humans, rats and mice in vitro. Boogaard PJ, de Kloe KP, Bierau J, Kuiken G, Borkulo PE, Watson WP, van Sittert NJ. Xenobiotica; 2000 May 15; 30(5):485-502. PubMed ID: 10875682 [Abstract] [Full Text] [Related]
60. Species comparison of acrylonitrile epoxidation by microsomes from mice, rats and humans: relationship to epoxide concentrations in mouse and rat blood. Roberts AE, Kedderis GL, Turner MJ, Rickert DE, Swenberg JA. Carcinogenesis; 1991 Mar 15; 12(3):401-4. PubMed ID: 2009586 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]